NASDAQ:INBS Intelligent Bio Solutions (INBS) Stock Price, News & Analysis → These AI trades triggered this morning (545% return) (From Prosper Trading Academy) (Ad) Free INBS Stock Alerts $2.55 +0.08 (+3.24%) (As of 09:03 AM ET) Add Compare Share Share Today's Range$2.55▼$2.5550-Day Range$2.57▼$5.5752-Week Range$2.28▼$49.20Volume1,326 shsAverage Volume2.54 million shsMarket Capitalization$7.24 millionP/E RatioN/ADividend YieldN/APrice TargetN/A Stock AnalysisStock AnalysisChartCompetitorsEarningsFinancialsHeadlinesInsider TradesSEC FilingsShort InterestSocial MediaStock AnalysisChartCompetitorsEarningsFinancialsHeadlinesInsider TradesSEC FilingsShort InterestSocial Media Get Intelligent Bio Solutions alerts: Email Address Ad TranzactWhat is Medicare Supplement Insurance?Original Medicare helps covers a lot of hospital and medical services, but it still leaves some out- of- pocket medical costs to recipients. Make sure your family’s nest egg is protected from unpredictable medical expenses. Consider applying for a Medicare Supplement Insurance Plan that travels with you. Learn More Here About Intelligent Bio Solutions Stock (NASDAQ:INBS)Intelligent Bio Solutions Inc., a medical technology company, developing non-invasive, real-time monitoring, and diagnostic tests for patients and their primary health practitioners. It offers saliva glucose biosensor for diabetes management that measures glucose in saliva. The company also provides intelligent fingerprinting drug screening system, a revolutionizing portable testing through fingerprint sweat analysis, which has the potential for broader applications in additional fields; and biosensor platform for biochemistry, immunology, tumor markers, hormones, and nucleic acid diagnostic modalities. The company was formerly known as GBS Inc. and changed its name to Intelligent Bio Solutions Inc. in October 2022. The company was incorporated in 2016 and is headquartered in New York, New York. Intelligent Bio Solutions Inc. is a subsidiary of Life Science Biosensor Diagnostics Pty Ltd.Read More INBS Stock Price History View Price History Chart DataSkip Price History Chart 30 days | 90 days | 365 days | Advanced Chart INBS Stock News HeadlinesApril 19, 2024 | americanbankingnews.comIntelligent Bio Solutions (NASDAQ:INBS) Trading 4.5% Higher April 18, 2024 | finanznachrichten.deIntelligent Bio Solutions, Inc.: Intelligent Bio Solutions Inc. Announces Preliminary Unaudited Fiscal Third Quarter and Nine-Month Revenue ResultsApril 26, 2024 | Colonial Metals (Ad)Conflict In Israel Sends Gold Soaring ???? Here’s How To Get Your ShareThe latest flare-up between Israel and Palestinian militants has sent gold prices surging. Why? Because savvy investors know the endgame of the elites at play… Geopolitical crises breed uncertainty — and gold thrives on uncertainty. April 18, 2024 | globenewswire.comIntelligent Bio Solutions Inc. Announces Preliminary Unaudited Fiscal Third Quarter and Nine-Month Revenue ResultsApril 11, 2024 | globenewswire.comIntelligent Bio Solutions Subsidiary Broadens Intellectual Property Portfolio with Grant of New European Patent with Unitary Effect for Innovative Intelligent Fingerprinting DSR-Plus Cartridge ReaderMarch 26, 2024 | globenewswire.comIntelligent Bio Solutions to Present at the LD Micro Invitational XIV Investor Conference on April 9 in NYCMarch 12, 2024 | globenewswire.comIntelligent Bio Solutions Announces Closing of $10.1 Million Private Placement Priced At-the-Market Under Nasdaq RulesMarch 11, 2024 | msn.comIntelligent BIO Ekes up on Private PlacementApril 26, 2024 | Colonial Metals (Ad)Conflict In Israel Sends Gold Soaring ???? Here’s How To Get Your ShareThe latest flare-up between Israel and Palestinian militants has sent gold prices surging. Why? Because savvy investors know the endgame of the elites at play… Geopolitical crises breed uncertainty — and gold thrives on uncertainty. March 11, 2024 | markets.businessinsider.comIntelligent Bio Solutions Announces $10.1 Mln Private PlacementMarch 11, 2024 | finance.yahoo.comIntelligent Bio Solutions Announces $10.1 Million Private Placement Priced At-the-Market Under Nasdaq RulesMarch 11, 2024 | globenewswire.comIntelligent Bio Solutions Announces $10.1 Million Private Placement Priced At-the-Market Under Nasdaq RulesMarch 1, 2024 | globenewswire.comIntelligent Bio Solutions Inc. to Present at the Emerging Growth Conference on March 6, 2024February 29, 2024 | msn.comIntelligent Bio Solutions seeks 510(k) approval with drug screening studyFebruary 28, 2024 | finanznachrichten.deIntelligent Bio Solutions, Inc.: Intelligent Bio Solutions Partners with Cliantha Research to Conduct Clinical Study as Part of FDA 510(k) PathwayFebruary 28, 2024 | globenewswire.comIntelligent Bio Solutions Partners with Cliantha Research to Conduct Clinical Study as Part of FDA 510(k) PathwayFebruary 20, 2024 | benzinga.comPeering Into Intelligent Bio Solutions's Recent Short InterestFebruary 16, 2024 | finance.yahoo.comIntelligent Bio Solutions Inc. Regains Compliance with Nasdaq Minimum Bid Price Requirement and Confirms Compliance with Minimum Stockholders’ Equity RequirementFebruary 16, 2024 | globenewswire.comIntelligent Bio Solutions Inc. Regains Compliance with Nasdaq Minimum Bid Price Requirement and Confirms Compliance with Minimum Stockholders' Equity RequirementFebruary 11, 2024 | finance.yahoo.comIntelligent Bio Solutions Second Quarter 2024 Earnings: EPS Beats Expectations, Revenues LagFebruary 9, 2024 | finance.yahoo.comIntelligent Bio Solutions Inc. Reports Fiscal Second Quarter and Six-Month Financial Results and Operational HighlightsFebruary 5, 2024 | msn.comWhy Is Intelligent Bio Solutions Stock Tumbling Today?February 5, 2024 | finance.yahoo.comIntelligent Bio Solutions Inc. Announces Exercise of Previously Issued Warrants for $1.77 Million in Gross ProceedsFebruary 2, 2024 | msn.comWhy Intelligent Bio Solutions Shares Are Skyrocketing TodayFebruary 2, 2024 | markets.businessinsider.comIntelligent Bio Solutions Expects Higher Q2 Revenue, Stock Up In Pre-MarketFebruary 2, 2024 | finance.yahoo.comIntelligent Bio Solutions Inc. Announces Preliminary Unaudited Fiscal Second Quarter and Six-Month Revenue ResultsJanuary 30, 2024 | finance.yahoo.comFingerprint Drug Test Delivers Quantifiable Benefits for Customers as Adoption in Workplaces AcceleratesSee More Headlines Receive INBS Stock News and Ratings via Email Sign-up to receive the latest news and ratings for Intelligent Bio Solutions and its competitors with MarketBeat's FREE daily newsletter. Email Address Company Calendar Last Earnings2/09/2024Today4/26/2024Next Earnings (Estimated)5/09/2024Fiscal Year End6/30/2024Get Stock AlertsIndustry, Sector and Symbol Stock ExchangeNASDAQ SectorMedical Industry Surgical & medical instruments Sub-IndustryN/A Current SymbolNASDAQ:INBS CUSIPN/A CIK1725430 Webgbs.inc Phone646-828-8258FaxN/AEmployees51Year FoundedN/AProfitability EPS (Most Recent Fiscal Year)($106.1510) Trailing P/E RatioN/A Forward P/E RatioN/A P/E GrowthN/ANet Income$-10,630,000.00 Net Margins-544.63% Pretax Margin-546.02% Return on Equity-266.16% Return on Assets-96.52% Debt Debt-to-Equity Ratio0.07 Current Ratio0.57 Quick Ratio0.39 Sales & Book Value Annual Sales$1.26 million Price / Sales5.57 Cash FlowN/A Price / Cash FlowN/A Book Value$18.99 per share Price / Book0.13Miscellaneous Outstanding Shares2,840,000Free Float2,836,000Market Cap$7.01 million OptionableNot Optionable Beta4.82 10 Best Stocks to Own in 2024Click the link below and we'll send you MarketBeat's list of the 10 best stocks to own in 2024 and why they should be in your portfolio. Get This Free Report Key ExecutivesMr. Harry Simeonidis (Age 57)President & CEO Comp: $310.79kMr. Spiro Kevin Sakiris B.Bus (Age 62)C.A., CA, Dip Law, Chief Financial Officer Comp: $274.43kMs. Victoria Gavrilenko (Age 41)Operations Manager Comp: $45kMr. Alex ArzenoVP of Investor RelationsKey CompetitorsVapothermNYSE:VAPOVivos TherapeuticsNASDAQ:VVOSPlus TherapeuticsNASDAQ:PSTVNeuroMetrixNASDAQ:NUROAvingerNASDAQ:AVGRView All CompetitorsInsidersHarry SimeonidisBought 8 shares on 8/31/2023Total: $184.32 ($23.04/share)View All Insider Transactions INBS Stock Analysis - Frequently Asked Questions How have INBS shares performed in 2024? Intelligent Bio Solutions' stock was trading at $4.0548 at the beginning of the year. Since then, INBS stock has decreased by 37.1% and is now trading at $2.55. View the best growth stocks for 2024 here. Are investors shorting Intelligent Bio Solutions? Intelligent Bio Solutions saw a decrease in short interest during the month of March. As of March 31st, there was short interest totaling 71,600 shares, a decrease of 21.3% from the March 15th total of 91,000 shares. Based on an average trading volume of 3,150,000 shares, the days-to-cover ratio is currently 0.0 days. Approximately 2.5% of the company's stock are short sold. View Intelligent Bio Solutions' Short Interest. When is Intelligent Bio Solutions' next earnings date? The company is scheduled to release its next quarterly earnings announcement on Thursday, May 9th 2024. View our INBS earnings forecast. How were Intelligent Bio Solutions' earnings last quarter? Intelligent Bio Solutions Inc. (NASDAQ:INBS) released its quarterly earnings results on Friday, February, 9th. The company reported ($2.07) earnings per share (EPS) for the quarter, beating the consensus estimate of ($3.24) by $1.17. The business earned $0.76 million during the quarter. Intelligent Bio Solutions had a negative net margin of 544.63% and a negative trailing twelve-month return on equity of 266.16%. When did Intelligent Bio Solutions' stock split? Shares of Intelligent Bio Solutions reverse split on Monday, January 29th 2024. The 1-12 reverse split was announced on Monday, January 29th 2024. The number of shares owned by shareholders was adjusted after the market closes on Monday, January 29th 2024. An investor that had 100 shares of stock prior to the reverse split would have 8 shares after the split. What guidance has Intelligent Bio Solutions issued on next quarter's earnings? Intelligent Bio Solutions issued an update on its third quarter 2024 earnings guidance on Thursday, April, 18th. The company provided earnings per share guidance of for the period. The company issued revenue guidance of 820000.000-820000.000, compared to the consensus revenue estimate of $1.2 million. How do I buy shares of Intelligent Bio Solutions? Shares of INBS stock can be purchased through any online brokerage account. Popular online brokerages with access to the U.S. stock market include Charles Schwab, E*TRADE, Fidelity, and Vanguard Brokerage Services. Compare Top Brokerages Here. This page (NASDAQ:INBS) was last updated on 4/26/2024 by MarketBeat.com Staff From Our PartnersConflict In Israel Sends Gold Soaring ???? Here’s How To Get Your ShareColonial MetalsThese AI trades triggered this morning (545% return)Prosper Trading AcademyThe Best AI Stock to Own in the World Today is Trading for Just $25Banyan Hill PublishingRed Alert: Your Money's Disappearance Act - Banks' Greed Unleashed!Priority GoldThe A.I. story nobody is telling you (Read ASAP)TradeSmithDid You Get Your Free Bitcoin Yet?Crypto Swap ProfitsTrump is sounding the alarmPreserve GoldBitcoin Rockets To Record High But Buy THIS InsteadParadigm Press Adding Choose a watchlist: Watchlist Adding You have already added five stocks to your watchlist. Upgrade to MarketBeat All Access to add more stocks to your watchlist. Adding Intelligent Bio Solutions Inc. Please log in to your account or sign up in order to add this asset to your watchlist. Get 30 Days of MarketBeat All Access Free Sign up for MarketBeat All Access to gain access to MarketBeat's full suite of research tools: Best-in-Class Portfolio Monitoring View the latest news, buy/sell ratings, SEC filings and insider transactions for your stocks. Compare your portfolio performance to leading indices and get personalized stock ideas based on your portfolio. Stock Ideas and Recommendations Get daily stock ideas from top-performing Wall Street analysts. Get short term trading ideas from the MarketBeat Idea Engine. View which stocks are hot on social media with MarketBeat's trending stocks report. Advanced Stock Screeners and Research Tools Identify stocks that meet your criteria using seven unique stock screeners. See what's happening in the market right now with MarketBeat's real-time news feed. Export data to Excel for your own analysis. Start Your 30-Day Free Trial Sign in to your free account to enjoy these benefits In-depth profiles and analysis for 20,000 public companies. Real-time analyst ratings, insider transactions, earnings data, and more. Our daily ratings and market update email newsletter. Sign in to your free account to enjoy all that MarketBeat has to offer. Sign In Create Account Your Email Address: Email Address Required Your Password: Password Required or Sign in with Facebook Sign in with Google Forgot your password? Your Email Address: Please enter your email address. Please enter a valid email address Choose a Password: Please enter your password. Your password must be at least 8 characters long and contain at least 1 number, 1 letter, and 1 special character. Create My Account (Free) or Sign in with Facebook Sign in with Google By creating a free account, you agree to our terms of service. This site is protected by reCAPTCHA and the Google Privacy Policy and Terms of Service apply.